The purpose of this study is to demonstrate whether and to what extent a single injection of platelet‐rich plasma (PRP), under ultrasound guidance, can improve the clinical symptoms of patients with a mild to moderate carpal tunnel syndrome (CTS). We conducted a prospective, randomized, clinical study including 50 patients suffering from mild to moderate CTS for a minimum duration of 3 months. Patients were randomly divided into 2 groups: Group A (26 patients) received an ultrasound‐guided PRP injection into the carpal tunnel, whereas Group B (24 patients) was injected with placebo (0.9% normal saline). The short‐ and mid‐term outcomes were determined with the use of the Q‐DASH questionnaire and the pain scale VAS administered at 0, 4, and 12 weeks follow‐up. The success ratio was determined by the difference in the Q‐DASH obtained pre‐injection minus the final Q‐DASH obtained after 12 weeks follow‐up. Success was defined as a difference more than 25%. Group A patients demonstrated a 76.9% success as determined by the difference Q‐DASH, whereas Group B patients demonstrated 33.3% success, which was significantly less than Group A (Χ2, p = .011). The findings of this study suggest that a single PRP ultrasound‐guided injection has positive effects in patients with CTS.
Journal of Tissue Engineering and Regenerative Medicine – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera